vemurafenib cscc ras increases incidence mrna
vemurafenib patients naive treatment wikidoc arm survival efficacy summarize dacarbazine compared results control figure table
vemurafenib sensitive characterization cells
vemurafenib tumor treatment responses braf v600e pdx resistance
mitf vemurafenib induction trametinib dependent